pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

999 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT776Endpoints580BioPharma Dive223onclive165Fierce Biotech54BioSpace52raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6Hematology
  • STAT+: NIH staffers published a letter of dissent a year ago. They feel it’s been ignored
    In a report published on the first anniversary of the Bethesda Declaration, 71 staffers write that they feel NIH leadership “largely ignored" their concerns.
    STAT · 1mo ago↗ source
  • STAT+: What’s changed since the last major Ebola outbreak
    A suppressed federal alcohol report, an "inevitable development" for wearables data, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Opinion: Ending animal testing could set back xenotransplantation just as the field is poised for a breakthrough
    “Innovations like xenotransplantation would never have reached clinical trials without animal experimentation,” writes transplant surgeon Joshua Mezrich.
← prev
page 20 of 40
next →
6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
STAT · 1mo ago
↗ source
  • STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic
    Wearables generate a lot of health data, but it exists outside the clinic for the most part. New moves from Oura and Whoop may change that.
    STAT · 1mo ago↗ source
  • Opinion: Why STAT is sticking with ‘health care’ as two words
    Is it “health care” or “healthcare”? STAT readers had strong feelings.
    STAT · 1mo ago↗ source
  • STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leaders
    Hospital execs say they're working to mitigate the impacts of the looming cuts.
    STAT · 1mo ago↗ source
  • A leader of the 2014 U.S. Ebola response compares then to now
    As the world deals with an outbreak of Ebola that has no known cure, Susan Reichle, who last year co-founded Aid Transition Alliance to support former USAID professionals, discusses the…
    STAT · 1mo ago↗ source
  • STAT+: GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
    GSK is buying Nuvalent, the maker of targeted cancer drugs, for $10.6 billion, a sizable addition to the latest run of biopharma acquisitions.
    STAT · 1mo ago↗ source
  • Alcohol study discarded by Trump officials is published in scientific journal
    A government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light drinking.
    STAT · 1mo ago↗ source
  • Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or rest
    Health workers at the epicenter of Congo's Ebola outbreak are laboring with little pay or rest.
    STAT · 1mo ago↗ source
  • STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
    AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
    STAT · 1mo ago↗ source
  • City banks nearly $100M for next-gen RNAi drugs
    <figure><div><img src="https://imgproxy.divecdn.com/pxC2yW1qZhMv8FFHGtViPA2KryY3_Pfu7kxPvvCensY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjk3MDM0MzI5LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Roche stakes $700M on Nurix’s protein-degrading drug
    <p>Potentially worth up to $2.3 billion, the collaboration is a bet that drugs able to eliminate the “BTK” enzyme will prove superior to existing medicines that block its activity.</p>
    BioPharma Dive · 1mo ago↗ source
  • Tango data add to growing momentum for pancreatic cancer drugs
    <figure><div><img src="https://imgproxy.divecdn.com/WEayUdfuHXoOw2FpmsOFLF4yn7KYNOFOwzm5w7xXaT4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzE4Mjc5OTExLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Incyte to buy blood disorder drug in possibly $2B deal
    <figure><div><img src="https://imgproxy.divecdn.com/2QfDLQx7Ry-HALZnt9wJeCfUZIiqFEeEOc-a7yHR_O8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzY2OTU4MDU4LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • J&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for $1B
    <figure><div><img src="https://imgproxy.divecdn.com/8ktp2N_0bECPaVaqEXe_a9D0QIm8s6Dv94O0ycnj0SA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9KSl9Mb2JieTAxX0hpZ2hSZXNfQzlXdTlwT…
    BioPharma Dive · 1mo ago↗ source
  • ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
    <figure><div><img src="https://imgproxy.divecdn.com/s1OP69WlFaq8Ze7MFeyEVPnIDEywrEml5dBx5ZtKpus/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNjY1Nzc4NTU4XzEua…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: UnitedHealthcare’s lactation billing feud, and fake strokes
    The biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.
    STAT · 1mo ago↗ source
  • STAT+: Novo underwhelmed by drug it once fought Pfizer for
    Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
    Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide
    STAT · 1mo ago↗ source
  • STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments
    Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.
    STAT · 1mo ago↗ source
  • Major readouts from the annual diabetes conference
    Why "Schedule F" matters, the Ebola outbreak response, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rate
    A combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.
    STAT · 1mo ago↗ source
  • Innovation alone is no longer enough in biopharma
    <p>In biopharma, the next edge may come from the systems that turn discovery into scale.</p>
    BioPharma Dive · 1mo ago↗ source
  • Precision under pressure: Logistic solutions for nuclear medicine scalability
    <p>Racing the clock: How precision logistics deliver life-saving nuclear medicine.</p>
    BioPharma Dive · 1mo ago↗ source